FINWIRES · TerminalLIVE
FINWIRES

Craig Hallum Downgrades Apogee Therapeutics to Hold From Buy, $135.11 Price Target

By

Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $122.86, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $132.63, Change: $+42.25, Percent Change: +46.75%

Related Articles